Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004148152 | SCV003628666 | uncertain significance | not specified | 2022-07-12 | criteria provided, single submitter | clinical testing | The c.421G>A (p.A141T) alteration is located in exon 3 (coding exon 1) of the RPP38 gene. This alteration results from a G to A substitution at nucleotide position 421, causing the alanine (A) at amino acid position 141 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |